leflunomide has been researched along with B-Cell Lymphoma in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a 67-year-old woman with a 30-year history of rheumatoid arthritis, who had received treatment with leflunomide for 10 years and infliximab for 2 years." | 3.83 | Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist. ( Ameur, F; Benzerdjeb, N; Ikoli, JF; Sevestre, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benzerdjeb, N | 1 |
| Ameur, F | 1 |
| Ikoli, JF | 1 |
| Sevestre, H | 1 |
| Papageorgiou, C | 1 |
| Albert, R | 1 |
| Andersen, E | 1 |
| Zurini, M | 1 |
| Hungerford, V | 1 |
| Floersheim, P | 1 |
| Schreier, MH | 1 |
2 other studies available for leflunomide and B-Cell Lymphoma
| Article | Year |
|---|---|
Primary cardiac B cell lymphoma: Manifestation of Felty's syndrome or TNFα antagonist.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Felty Syndrome; Female; Heart Neoplasms; Humans; | 2016 |
Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
Topics: Aniline Compounds; Animals; Antigens, Heterophile; B-Lymphocytes; Biphenyl Compounds; Cell Division; | 2001 |